 |
 |

Monoamine Neurotransmitter Interactions and the Prediction of Antidepressant Response
John K. Hsiao, MD;
Hans Agren, MD;
John J. Bartko, PhD;
Matthew V. Rudorfer, MD;
Markku Linnoila, MD, PhD;
William Z. Potter, MD, PhD
Arch Gen Psychiatry. 1987;44(12):1078-1083.
Abstract
 |  |
Clinical studies of monoamine neurotransmitter function in depression have concentrated on individual monoamines without focusing on interactions between monoamine systems. Virtually all modern studies have found significant correlations between monoamine metabolite concentrations in cerebrospinal fluid (CSF). These correlations should in part reflect interactions between central monoamine systems. In the present analysis, CSF had been obtained from depressed patients before (n = 40) and after (n =36) antidepressant treatment. The patients were grouped based on their response to treatment. Absolute concentrations of CSF monoamine metabolites (homovanillic acid, 5-hydroxyindoleacetic acid, and 3-methoxy-4-hydroxyphenylethyleneglycol) did not differ between the two groups before or after treatment. However, when correlations between metabolites were compared, nonresponders to treatment differed considerably from responders. In responders, as in previously described normal populations, all three metabolites correlated with one another before and after treatment, and treatment-induced changes in metabolite concentrations also correlated with one another. In contrast, metabolites in nonresponders did not correlate with one another before treatment, nor did treatment-induced changes correlate with one another in this group. Furthermore, correlations between treatment-induced changes in metabolites differed significantly between responders and nonresponders, and there was a trend for pretreatment correlations to differ as well. The lack of correlation between monoamine metabolites in nonresponders suggests that interactions between monoamine systems may be disrupted in these individuals. Using CSF metabolite correlations to study neurotransmitter interactions may have clinical relevance and yields information not available from examining neurotransmitters in isolation.
Author Affiliations
From the Section on Clinical Pharmacology, Laboratory of Clinical Sciences (Drs Hsiao, Agren, Rudorfer, and Potter), and the Division of Biometry and Applied Sciences (Dr Bartko), National Institute of Mental Health, Bethesda, Md; the Department of Psychiatry, University Hospital, Uppsala, Sweden (Dr Agren); and the Laboratory of Clinical Studies, National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Biological Research, Bethesda, Md (Dr Linnoila).
Footnotes
Accepted for publication Aug 4, 1987.
Reprint requests to Section on Clinical Pharmacology, Laboratory of Clinical Science, NIMH, Bldg 10, Room 2D46, Bethesda, MD 20892 (Dr Hsiao).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Differential Brain Metabolic Predictors of Response to Paroxetine in Obsessive-Compulsive Disorder Versus Major Depression
Saxena et al.
Am. J. Psychiatry 2003;160:522-532.
ABSTRACT
| FULL TEXT
Signal Transduction Pathways: Molecular Targets for Lithium's Actions
Manji et al.
Arch Gen Psychiatry 1995;52:531-543.
ABSTRACT
Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine
Altemus et al.
Arch Gen Psychiatry 1994;51:794-803.
ABSTRACT
Effect of Neuroleptic Medication on Cerebrospinal Fluid Monoamine Metabolite Concentrations in Schizophrenia: Serotonin-Dopamine Interactions as a Target for Treatment
Kahn et al.
Arch Gen Psychiatry 1993;50:599-605.
ABSTRACT
Monoamine Neurotransmitter Interactions in Drug-Free and Neuroleptic-Treated Schizophrenics
John et al.
Arch Gen Psychiatry 1993;50:606-614.
ABSTRACT
Are Monoamine Metabolites in Cerebrospinal Fluid Worth Measuring?
Arch Gen Psychiatry 1993;50:653-656.
ABSTRACT
The Mechanisms of Action of Lithium: II. Effects on Adenylate Cyclase Activity and {beta}-Adrenergic Receptor Binding in Normal Subjects
Risby et al.
Arch Gen Psychiatry 1991;48:513-524.
ABSTRACT
Cerebrospinal Fluid and Plasma Monoamine Metabolites and Their Relation to Psychosis: Implications for Regional Brain Dysfunction in Schizophrenia
Pickar et al.
Arch Gen Psychiatry 1990;47:641-648.
ABSTRACT
Serotonergic Studies in Patients With Affective and Personality Disorders: Correlates With Suicidal and Impulsive Aggressive Behavior
Coccaro et al.
Arch Gen Psychiatry 1989;46:587-599.
ABSTRACT
Biochemical Classifications of Diagnostic Subgroups and D-Type Scores
Potter and Linnoila
Arch Gen Psychiatry 1989;46:269-271.
ABSTRACT
|